Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds
NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer
Two-Point Rise In PSA Signals High-Risk Prostate Cancer
High Cervical Cancer Rates Indicate Access Problems
Lifestyle Changes Common After Cancer Diagnosis
Proton Beam Radiation Helps Cancer Patients Retain Vision
Cooperative Group Trials Approved By NCI Are Listed
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
- The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community
